![Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions](https://s40123.pcdn.co/wp-content/uploads/2022/03/recallTeva-700x547.jpg)
Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions
![Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times](https://m.economictimes.com/thumb/msid-54696609,width-1200,height-900,resizemode-4,imgsize-173278/intas-buys-tevas-uk-ireland-assets-for-764-million-to-break-into-global-top-20-generic-players-club.jpg)
Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times
![Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, Join a Growing List of Provinces Providing Public Drug Plan Reimbursement for Teva Canada's AJOVY® (fremanezumab), for the Preventive Treatment of Migraine in Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, Join a Growing List of Provinces Providing Public Drug Plan Reimbursement for Teva Canada's AJOVY® (fremanezumab), for the Preventive Treatment of Migraine in](https://mms.businesswire.com/media/20220512006052/en/1454377/5/AJOVY_BOX_%2825_%29.jpg)
Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland, Join a Growing List of Provinces Providing Public Drug Plan Reimbursement for Teva Canada's AJOVY® (fremanezumab), for the Preventive Treatment of Migraine in
![USFDA: Teva Pharmaceutical recalls 38,858 bottles of drugs made by Emcure Pharmaceuticals in US market - The Economic Times USFDA: Teva Pharmaceutical recalls 38,858 bottles of drugs made by Emcure Pharmaceuticals in US market - The Economic Times](https://img.etimg.com/thumb/width-1200,height-900,imgsize-22194,resizemode-1,msid-35482570/industry/healthcare/biotech/pharmaceuticals/teva-pharmaceutical-recalls-38858-bottles-of-drugs-made-by-emcure-pharmaceuticals-in-us-market.jpg)